Related Experiment Video
Updated: May 29, 2026
04:12
Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
Published on: January 19, 2024
Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders
Mercedes Gómez Vázquez1, Ramón Navarra Amayuelas, Marta Lamarca
1Deparment of Dermatology, Hospital Municipal of Badalona, Badalona, Barcelona, Spain.
American Journal of Clinical Dermatology
|September 8, 2011
Summary
Combined oral contraceptives, specifically ethinylestradiol/chlormadinone acetate (EE/CMA), effectively managed dermatological conditions like hair loss, acne, and hirsutism in four cases. EE/CMA proved beneficial for patients with and without hyperandrogenization.
Area of Science:
- Dermatology
- Endocrinology
- Pharmacology
Background:
- Dermatological conditions such as androgenetic alopecia, acne, and hirsutism can be linked to androgen excess.
- Combined oral contraceptives (COCs) offer a potential therapeutic avenue for managing these conditions, especially when hormonal therapy is required or contraception is a consideration.
Observation:
- Case 1: A female patient with androgenetic alopecia experienced stabilized hair loss after 6 months of EE/CMA treatment.
- Case 2: A patient with acne and irregular menses, diagnosed with polycystic ovary syndrome (PCOS), showed reduced acne and normalized menses with EE/CMA.
- Case 3: Idiopathic hirsutism improved with EE/CMA treatment, with reduced hair growth reported.
- Case 4: A patient with PCOS, acne, seborrhea, and mild hirsutism experienced significant improvements in all symptoms and achieved eumenorrhea with EE/CMA.
Findings:
- Ethinylestradiol/chlormadinone acetate (EE/CMA) at 0.03 mg/2 mg demonstrated efficacy in managing diverse dermatological issues.
- The treatment was well-tolerated across all presented cases.
- EE/CMA provided therapeutic benefits for conditions with and without underlying hyperandrogenization.
Implications:
- EE/CMA represents a viable and well-tolerated treatment option for dermatological disorders associated with androgen excess.
- This study highlights the utility of COCs in addressing complex dermatological presentations in women.
- Further research may explore the broader application of EE/CMA in managing similar endocrine-related skin conditions.
Related Concept Videos
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:24Cholinergic Antagonists: Pharmacokinetics
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.
01:26Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...